Analysis of Overall Survival Benefit of Abemaciclib Plus Fulvestrant in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer.

Overview
Identity
Additional Document Info
View All

authors

Sun, Ryan
Dae Hyun Kim, MD, MPH, ScD
Wei, Lee-Jen

publication date

January 1, 2020

published in

JAMA oncology Journal

has subject area